Bedrood describes improved visualization of the ciliary body, efficient setup, and favorable postoperative outcomes.

Glaukos announced that the FDA has approved the new drug application for its topical drug therapy (Epioxa HD/Epioxa) for keratoconus. 1,2 This approval makes it the first FDA-approved corneal ...

Innovations in selective laser trabeculoplasty and laser cyclophotocoagulation focus on procedural efficiency, patient ...

Ophthalmologists from across the United States and around the globe gathered in Orlando, Florida over the October 17 through ...

John P. Berdahl, MD, a surgeon at Vance Thompson Vision and a professor at the University of South Dakota, spoke on the lens ...

Ophthalmology Times: What are the most striking differences in anatomic outcomes (GA lesion growth, photoreceptor ...

Philip J. Ferrone, MD, is partner with Vitreoretinal Consultants of New York and professor of ophthalmology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.

Pickleball's popularity surged, with a 311% increase in players since 2020, reaching 19.8 million in 2024. A cross-sectional ...

The American Academy of Ophthalmology (AAO) is hosting its annual scientific meeting in Orlando, Florida from October 17 ...

A key area of practice management and sustainability initiatives is ensuring that waste is reduced whenever possible. In a ...

Ken Beckman, MD, FACS, is a corneal specialist and clinical assistant professor at The Ohio State University. At the 2025 ...

DAVIO-2 for wet AMD and VERONA for DME. In the DAVIO-2 trial, patients previously treated with approximately 10 injections in ...